Skip to main content
Premium Trial:

Request an Annual Quote

McGill University Sequences Genomeof Antibiotic-Resistant C. Difficile

NEW YORK, Dec. 14 (GenomeWeb News) - McGill University researchers and partners successfully sequenced the genome of a virulent strain of Clostridium difficile, the university said today.


The strain, also known as C. difficile, is a microbe that can cause an infection of the bowel and has been prevalent in Quebec since 2003. Similar to strains found elsewhere in the world, it is resistant to a group of antibiotics called fluoroquinolones. This is the second time worldwide that a strain of this microbe has been sequenced.


Funding for the project came from a variety of sources: Genome Quebec and Genome Canada, the Lady Davis Institute for Medical Research and the Jewish General Hospital Foundation.


McGill researchers, with scientists from Genome Quebec Innovation Centre, MUHC, and Jewish General Hospital, used the ultra high-throughput sequencing technology at the Genome Sequencing Center at the Washington University School of Medicine.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.